IP Library Granted Patent US 8,588,881
Granted Patent B2
US 8,588,881 · App. 11/681,713 · Granted Nov 19, 2013

Subcutaneous glucose electrode

Inventors: Adam Heller (Austin, TX); Michael V. Pishklo (Austin, TX)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,588,881
App. No.
11/681,713
Granted
Nov 19, 2013
Kind
B2
Abstract

A small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described. The electrode is designed to allow “one-point” in vivo calibration, i.e., to have zero output current at zero glucose concentration, even in the presence of other electroreactive species of serum or blood. The electrode is preferably three or four-layered, with the layers serially deposited within a recess upon the tip of a polyamide insulated gold wire. A first glucose concentration-to-current transducing layer is overcoated with an electrically insulating and glucose flux limiting layer (second layer) on which, optionally, an immobilized interference-eliminating horseradish peroxidase based film is deposited (third layer). An outer (fourth) layer is biocompatible.

Claims (31)

1. An analyte measurement system, comprising:

at least one sensor introducer;

a first electrochemical sensor having at least one electrode with an analyte response enzyme thereon, the first electrochemical sensor coupleable to the at least one sensor introducer for positioning at least a portion of the first electrochemical sensor under a skin surface;

a second electrochemical sensor having at least one electrode with an analyte response enzyme thereon, the second electrochemical sensor coupleable to the at least one sensor introducer for positioning at least a portion of the second electrochemical sensor under a skin surface; and

a device configured to normalize a signal obtained from the first electrochemical sensor with respect to a signal obtained from the second electrochemical sensor, to determine a standard deviation for a difference between the normalized signal of the first electrochemical sensor and the signal obtained from the second electrochemical sensor, to reject the signals of the first electrochemical sensor and the second electrochemical sensor that differ by more than the standard deviation, and to calibrate the signal obtained from the first electrochemical sensor based on a calibration factor.

2. The system of claim 1 wherein at least one electrode of the one or more of the first sensor or the second sensor comprises gold, platinum, palladium, or carbon.

3. The system of claim 1 wherein the signal from the first electrochemical sensor is calibrated using a blood sample.

4. The system of claim 1 wherein the signal from the first electrochemical sensor is calibrated using single point calibration.

5. The system of claim 1 wherein the analyte is glucose.

6. The system of claim 1 wherein at least one of the first electrochemical sensor and the second electrochemical sensor is implanted.

7. The system of claim 6 wherein the at least one of the first electrochemical sensor and the second electrochemical sensor is implanted subcutaneously.

8. The system of claim 1 wherein at least the one electrode of at least one of the first electrochemical sensor or the second electrochemical sensor is implanted.

9. A method, comprising:

positioning, using a sensor introducer, at least a portion of at least one electrode of a first electrochemical sensor having analyte response enzyme thereon, in fluid contact with interstitial fluid, the first electrochemical sensor coupleable to the sensor introducer;

positioning, using the sensor introducer, at least a portion of at least one electrode of a second electrochemical sensor having analyte response enzyme thereon, in fluid contact with interstitial fluid, the second electrochemical sensor coupleable to the sensor introducer;

normalizing, using a device, a signal obtained from the first electrochemical sensor with respect to a signal obtained from the second electrochemical sensor;

determining, using the device, a standard deviation for a difference between the normalized signal of the first electrochemical sensor and the signal obtained from the second electrochemical sensor;

rejecting, using the device, the signals of the first electrochemical sensor and the second electrochemical sensor that differ by more than the standard deviation; and

calibrating, using the device, the signal obtained from the first electrochemical sensor based on a calibration factor.

10. The method of claim 9 further including determining whether at least one of the signal obtained from the first electrochemical sensor or the signal obtained from the second electrochemical sensor is valid based on the comparison.

11. The method of claim 9 further including measuring an analyte level of the interstitial fluid.

12. The method of claim 11 wherein measuring the analyte level includes measuring a glucose level of the interstitial fluid.

13. The method of claim 9 further including calibrating at least one of the signal obtained from the first electrochemical sensor or the signal obtained from the second electrochemical sensor using a blood sample.

14. The method of claim 9 further including calibrating using single point calibration at least one of the signal obtained from the first electrochemical sensor or the signal obtained from the second electrochemical sensor.

15. The method of claim 9 , wherein the first and second electrochemical sensors are positioned at different areas of a body.

16. The method of claim 9 , wherein the first and second electrochemical sensors are positioned at substantially the same area of a body.

17. The system of claim 1 , wherein the calibration factor is based on at least one signal from one of the first electrochemical sensor or the second electrochemical sensor and a glucose level from a blood sample.

18. The system of claim 1 wherein the device is configured to validate the signal from the second electrochemical sensor based on the signal from the first electrochemical sensor.

19. The system of claim 1 wherein the device is configured to validate a calibrated signal from the second electrochemical sensor based on the signal from the first electrochemical sensor.

20. The system of claim 1 wherein the device is configured to validate the signal from the second electrochemical sensor based on the calibrated signal from the first electrochemical sensor.

21. The system of claim 1 wherein the device is configured to validate a calibrated signal from the second electrochemical sensor based on the calibrated signal from the first electrochemical sensor.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2013
From: PISHKO, MICHAEL V.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 031130/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2013
From: HELLER, ADAM
To: E. HELLER & COMPANY
Reel/Frame 031130/0829 →
RATIFICATION OF ASSIGNMENTS Recorded Aug 31, 2013
From: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
To: THERASENSE, INC.
Reel/Frame 031130/0833 →
CHANGE OF NAME Recorded Aug 31, 2013
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 031130/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2013
From: E. HELLER & COMPANY
To: THERASENSE, INC.
Reel/Frame 031130/0852 →
Continuity (9)
Continuation 11109379 · Apr 19, 2005
Continuation 10353341 · Jan 28, 2003
Continuation 09997808 · Nov 29, 2001
Continuation 09668221 · Sep 22, 2000
Continuation 09477053 · Jan 3, 2000
Continuation 09356102 · Jul 16, 1999
Continuation 08767110 · Dec 4, 1996
Continuation 08299526 · Sep 1, 1994
Related Publication 20070151869A1 · Jul 5, 2007